Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-03 Exercise |
2025-03-04 5:27 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director |
27,666 | $3.75 | 74,200 (Direct) |
View |
2025-03-03 Exercise |
2025-03-04 5:27 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director |
20,500 | $6.33 | 74,200 (Direct) |
View |
2025-03-03 Exercise |
2025-03-04 5:27 pm |
N/A 2032-06-16 |
Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director |
48,166 | $0 | 74,200 (Direct) |
View |
2025-02-06 Option Award |
2025-02-10 5:39 pm |
N/A 2035-02-06 |
Enliven Therapeutics Inc. | ELVN | Kunkel Lori Anne Director |
15,368 | $0 | 15,368 (Direct) |
View |
2025-01-02 Option Award |
2025-01-06 4:46 pm |
N/A 2035-01-01 |
Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director |
35,000 | $0 | 35,000 (Direct) |
View |
2024-07-17 Gift |
2024-07-18 4:06 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director |
54,027 | $0 | 0 (Direct) |
View |
2024-06-12 Option Award |
2024-06-14 4:25 pm |
N/A 2034-06-11 |
Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director |
25,600 | $0 | 25,600 (Direct) |
View |
2024-06-03 Exercise |
2024-06-04 6:48 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director |
20,500 | $3.75 | 53,700 (Direct) |
View |
2024-06-03 Exercise |
2024-06-04 6:48 pm |
N/A 2032-06-16 |
Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director |
20,500 | $0 | 53,700 (Direct) |
View |
2024-05-20 Option Award |
2024-05-20 7:26 pm |
N/A 2034-05-19 |
Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director |
25,000 | $0 | 25,000 (Direct) |
View |
2024-04-08 Option Award |
2024-04-10 8:39 pm |
N/A 2034-04-08 |
Enliven Therapeutics Inc. | ELVN | Kunkel Lori Anne Director |
37,882 | $0 | 37,882 (Direct) |
View |
Ownership |
2024-04-10 8:37 pm |
N/A N/A |
Enliven Therapeutics Inc. | ELVN | Kunkel Lori Anne Director |
0 | $0 | 65,625 (Direct) |
View |
2023-06-14 Option Award |
2023-06-15 4:56 pm |
N/A 2033-06-13 |
Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director |
20,500 | $0 | 20,500 (Direct) |
View |
2023-05-04 Option Award |
2023-05-04 7:56 pm |
N/A 2033-05-03 |
Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director |
25,000 | $0 | 25,000 (Direct) |
View |
2022-06-17 Option Award |
2022-06-17 8:23 pm |
N/A 2032-06-16 |
Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director |
53,700 | $0 | 53,700 (Direct) |
View |
2022-05-05 Option Award |
2022-05-06 5:23 pm |
N/A 2032-05-04 |
Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director |
17,500 | $0 | 17,500 (Direct) |
View |
2022-01-31 Option Award |
2022-01-31 5:33 pm |
N/A 2032-01-30 |
CURIS INC | CRIS | Kunkel Lori Anne Director |
85,000 | $0 | 85,000 (Direct) |
View |
2021-06-16 Option Award |
2021-06-17 7:48 pm |
N/A 2031-06-15 |
Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director |
16,625 | $0 | 16,625 (Direct) |
View |
2021-05-06 Option Award |
2021-05-24 7:49 pm |
N/A 2031-05-05 |
Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director |
17,500 | $0 | 17,500 (Direct) |
View |
2021-01-28 Option Award |
2021-01-29 4:30 pm |
N/A 2031-01-27 |
CURIS INC | CRIS | Kunkel Lori Anne Director |
33,000 | $0 | 33,000 (Direct) |
View |
Ownership |
2020-07-23 6:53 pm |
N/A N/A |
Nurix Therapeutics Inc. | NRIX | Kunkel Lori Anne Director |
0 | $0 | 58,332 (Direct) |
View |
2020-06-09 Option Award |
2020-06-10 5:09 pm |
N/A 2030-06-08 |
Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director |
28,515 | $0 | 28,515 (Direct) |
View |
Ownership |
2020-06-10 5:07 pm |
N/A N/A |
Oric Pharmaceuticals Inc. | ORIC | Kunkel Lori Anne Director |
0 | $0 | 0 (Direct) |
View |